BBGI Steps into High-Value Biobased Product Sector by Becoming Lead Investor of World-Class Biotech Firm Manus Bio Inc.
The two firms now form a joint venture, WIN Ingredients, with a plan to set up Southeast Asia’s first multiproduct Syn Bio plant.
BBGI and Manus Bio Inc. (Manus Bio), one of the world’s leading high-value biobased product manufacturers, have announced the establishment of their joint venture for the plan to produce and distribute high-value biobased products in Asia and especially Southeast Asia. Making Bt800million investment, BBGI is the Lead Investor of Manus Bio through Series B financing. Under the plan, the joint venture will construct Southeast Asia’s first multiproduct Synthetic Biology plant.